Cosmos Health Inc COSM.OQ reported a quarterly adjusted loss of 45 cents per share for the quarter ended September 30. The lone analyst forecast for the quarter was for a loss of 11 cents per share.
Revenue was $12.41 million; analysts expected $14.00 million.
Cosmos Health Inc's reported EPS for the quarter was a loss of 45 cents.
The company reported a quarterly loss of $8.38 million.
Cosmos Health Inc shares had fallen by 28.1% this quarter and lost 55.3% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts was unchanged in the last three months.
In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 1 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."
The average consensus recommendation for the pharmaceuticals peer group is also "buy"
Wall Street's median 12-month price target for Cosmos Health Inc is $4.00
This summary was machine generated from LSEG data November 18 at 10:01 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING | ESTIMATE | ACTUAL | BEAT, MET, MISSED |
Sep. 30 2024 | -0.11 | -0.45 | Missed |
Jun. 30 2024 | -0.14 | -0.15 | Missed |
Mar. 31 2024 | -0.14 | -0.11 | Beat |
Dec. 31 2023 | -0.20 | -1.73 | Missed |
Comments